文献速递母胎医学

通过父母外显子组测序诊断致死性或产前起病的常染色体隐性遗传病

Diagnosis of lethal or prenatal-onset autosomal recessive disorders by parental exome sequencing.
PubMed 文献 · Prenat Diagn · 2017-12-03

本研究对50对曾怀有致死性或产前起病疾病胎儿的夫妇进行父母外显子组测序,在26/50对(52%)中检出致病或可能致病变异,涉及24个不同基因;在2个及以上胎儿受累的夫妇中,18/29例(62%)获得遗传学诊断。作者认为父母外显子组测序是致死性或产前起病隐性遗传病遗传诊断的有力策略,具有高临床效用。

要点

  • 对50对夫妇进行父母外显子组测序,26/50对(52%)检出致病或可能致病变异。
  • 2个及以上胎儿受累的夫妇中,18/29例(62%)获得遗传学诊断。
  • 在胎儿DNA不足时,父母外显子组测序可提供遗传诊断。

核心结论

  • 作者结论:父母样本外显子组测序是致死性或产前起病隐性遗传病遗传诊断的有力策略,具有高临床效用。

研究设计与样本

  • 对连续50对夫妇进行父母外显子组测序,这些夫妇有1个或多个胎儿受累于致死性或产前起病疾病,所有病例均无足够胎儿DNA用于外显子组测序。

主要发现

  • 父母外显子组分析在26/50对夫妇(52%)中检出24个不同基因的杂合致病或可能致病变异。
  • 在2个或以上胎儿受累的夫妇中,18/29例(62%)获得遗传学诊断。
  • 多数病例临床特征为该疾病的典型表现,但其他病例由亚效变异导致或代表可变表型谱中最严重的形式。

关键数值与推荐

  • 选择分析标准:父母双方同一基因中的杂合罕见变异(MAF<0.001)。
  • 在胎儿DNA中检测可能的致病性变异以确认共分离。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Rare genetic disorders resulting in prenatal or neonatal death are genetically heterogeneous, but testing is often limited by the availability of fetal DNA, leaving couples without a potential prenatal test for future pregnancies. We describe our novel strategy of exome sequencing parental DNA samples to diagnose recessive monogenic disorders in an audit of the first 50 couples referred. METHOD: Exome sequencing was carried out in a consecutive series of 50 couples who had 1 or more pregnancies affected with a lethal or prenatal-onset disorder. In all cases, there was insufficient DNA for exome sequencing of the affected fetus. Heterozygous rare variants (MAF < 0.001) in the same gene in both parents were selected for analysis. Likely, disease-causing variants were tested in fetal DNA to confirm co-segregation. RESULTS: Parental exome analysis identified heterozygous pathogenic (or likely pathogenic) variants in 24 different genes in 26/50 couples (52%). Where 2 or more fetuses were affected, a genetic diagnosis was obtained in 18/29 cases (62%). In most cases, the clinical features were typical of the disorder, but in others, they result from a hypomorphic variant or represent the most severe form of a variable phenotypic spectrum. CONCLUSION: We conclude that exome sequencing of parental samples is a powerful strategy with high clinical utility for the genetic diagnosis of lethal or prenatal-onset recessive disorders. © 2017 The Authors Prenatal Diagnosis published by John Wiley & Sons Ltd.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Stals KL, Wakeling M, Baptista J, et al. Diagnosis of lethal or prenatal-onset autosomal recessive disorders by parental exome sequencing. Prenat Diagn. 2017. PMID: 29096039. doi:10.1002/pd.5175

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。